Lin Feng-Yen, Tsao Nai-Wen, Shih Chun-Ming, Lin Yi-Wen, Yeh Jong-Shiua, Chen Jaw-Wen, Nakagami Hironori, Morishita Ryuichi, Sawamura Tatsuya, Huang Chun-Yao
Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Division of Cardiology, Department of Internal Medicine and Cardiovascular Research Center, Taipei Medical University Hospital, Taipei, Taiwan.
Division of Cardiovascular Surgery, Taipei Medical University Hospital, Taipei, Taiwan.
PLoS One. 2015 May 27;10(5):e0123971. doi: 10.1371/journal.pone.0123971. eCollection 2015.
Late-outgrowth endothelial progenitor cells (EPCs) are stress-resistant and responsible for reparative functions in the cardiovascular system. Oxidized-LDL (oxLDL) plays a critical role in cardiovascular disease pathogenesis. However, it is largely unknown what the impacts of oxLDL are on late-outgrowth EPCs. This study aimed to investigate the concentration-related effects of oxLDL on EPC functions and related angiogenesis, in vitro and in vivo. In this study, early and late-outgrowth EPCs were generated from circulating human mononuclear cells. oxLDL may regulate EPC vasculogenic function via the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1). Lower concentrations (5 μg/mL) of oxLDL can potentiate EPC tube formation in vitro and in vivo by activating eNOS mechanisms, which are mediated by p38 MAPK- and SAPK/JNK-related pathways. Higher concentrations of oxLDL (10-50 μg/mL) impaired EPC function via the activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase pathways and consequent inhibition of eNOS activity, which could be reversed by anti-oxidants (diphenylene iodonium and apocynin) and gp91phox siRNA. In conclusion, oxLDL has concentration-dependent biphasic effects on human late-outgrowth EPC tube formation in vitro and in vivo.
晚期生长内皮祖细胞(EPCs)具有抗应激能力,在心血管系统中发挥修复功能。氧化型低密度脂蛋白(oxLDL)在心血管疾病发病机制中起关键作用。然而,oxLDL对晚期生长EPCs的影响在很大程度上尚不清楚。本研究旨在体外和体内研究oxLDL对EPC功能及相关血管生成的浓度依赖性影响。在本研究中,早期和晚期生长的EPCs由循环中的人单核细胞生成。oxLDL可能通过凝集素样氧化低密度脂蛋白受体-1(LOX-1)调节EPC的血管生成功能。较低浓度(5μg/mL)的oxLDL可通过激活由p38丝裂原活化蛋白激酶(MAPK)和应激活化蛋白激酶/ c-Jun氨基末端激酶(SAPK/JNK)相关途径介导的内皮型一氧化氮合酶(eNOS)机制,增强体外和体内EPC的管腔形成。较高浓度的oxLDL(10 - 50μg/mL)通过激活烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶途径并随后抑制eNOS活性来损害EPC功能,抗氧化剂(二苯碘鎓和载脂蛋白)和gp91phox小干扰RNA(siRNA)可逆转这种损害。总之,oxLDL在体外和体内对人晚期生长EPC的管腔形成具有浓度依赖性的双相作用。